NEW YORK (GenomeWeb News) — DNAPrint Genomics today said it has allied with BioServe to supply integrated clinical DNA samples tagged with genetic ancestral information to biomedical researchers.
Under the agreement, DNAPrint will use its genetic ancestry test to analyze and categorize BioServe’s Global Repository of nearly 600,000 human biological samples.
“With the added dimension of ancestry information to clinical samples, medical researchers will be able to determine whether certain biological markers are artifacts of genetic ancestry or are true markers for a disease or drug response in a disease,” the companies said in a joint statement.
DNAPrint CEO Richard Gabriel said that "by removing the question of ancestry from a clinical sample researchers can more readily evaluate which medicines will produce side effects within certain ethnic groups, and which medicines will work for the widest spectrum of a population.”
The agreement also allows the company to offer supportive services such as sample extraction and preparation, genotyping, and gene expression.
Financial terms of the deal were not released.